Discover 45 paid clinical trials in Montgomery, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 45
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
for
Kidney Disease
Location: 17 recruiting locations
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06963827
Phase3, Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: 50 recruiting locations
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: 28 recruiting locations
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Recruiting
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
for
Hiv, Alcohol Problem
Location: 5 recruiting locations
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT04955795
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
for
Proteinuric Kidney Disease
Location: 57 recruiting locations
Sponsor: Maze Therapeutics
Sex: All
Age: 18 - 68
Code: NCT06830629
Phase2, Recruiting
A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
for
Primary Membranous Nephropathy
Location: 14 recruiting locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07204275
Phase2, Phase3, Recruiting
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)
for
Hidradenitis Suppurativa
Location: 60 recruiting locations
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06958211
Phase3, Recruiting
To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis
for
Anemia of Chronic Kidney Disease
Location: 12 recruiting locations
Sponsor: Akebia Therapeutics
Sex: All
Age: 18+
Code: NCT06901505
Phase3, Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis